Printer Friendly

Calcium deficit in diet as risk factor for osteopenic syndrome in pregnant women of young age.

Osteopenic syndrome is currently widely considered among the most common pathologic conditions in developed countries (Benevolenskaya, 2003, CRIG, 2004). It is also known to be found more frequently in females (CRIG, 2004; Melton et al., 1997).

Up until the last decades, bone tissue mineral density (BTMD) deficiency has been associated with seniors. However, a large number of recent studies indicate that osteopenia and even development of osteoporosis is often found in people of young age, and predominantly young females (Benevolenskaya, 2004; Abdurazzakov, 2001).

Majority of scientists tend to believe that bone tissue mineral density deficiency in adults, especially young adults, can be attributed to the bone metabolism disorder and disbolism of calcium, phosphorus and other elements, suffered in childhood (Gafni and Baron, 2007).

Contributing to calcium--and phosphorus-related conditions are various factors: vitamin deficiency (mainly, vitamin D3); vitamin D disbolism due to immaturity of a number of enzyme systems; insufficient dietary intake of microelements; reduction of phosphorus and calcium intestinal absorption as well as their re-absorption in kidneys; endocrinal system disorder affecting phosphorus-calcium metabolism; microelemental status deficiencies and many other factors (Demin, 2005).

Several scientists have revealed a positive connection between life-long calcium intake and bone mineral density deficiency in young adults. Matkovic et al. analyzed the correlation of calcium balance and its consumption based on a survey conducted on 519 female patients from birth to the age of 30. As a result, primary determinant of calcium balance was found to be its consumption. On adolescent stage, calcium balance was increased; positive balance values have been attained by administering over 1500 mg per day, which resulted in elevation of bone mass peak (Matkovic et al., 2005). It was found especially significant to increase calcium administration in girls and young women of ages 12-19, as the average calcium consumption for this category is known to be 900 mg per day and therefore insufficient for adequate bone mass accumulation in future (Aspray and Francis, 2008).

Pregnancy introduces additional factors leading to further decrease of bone tissue mineral density. Of those, the leading one is the increased consumption of calcium, prompting its extraction from bone reserves. Thus, potential possibility of developing osteopenic syndrome related to insufficient consumption or assimilation in juvenile and adolescent ages can reveal itself in young women during pregnancy.

With this in mind, we have conducted a study of characteristics pertaining to the metabolism of calcium, magnesium and phosphorus as elements of highest importance in forming bone tissue in pregnant young females.

Study the features of bone tissue mineral density and their correlation to the blood levels of calcium, magnesium and inorganic phosphorus in pregnant female young adults.

Materials and methods

Clinical and ambulatory examination of 120 pregnant women of ages 16-25 (median age 21.7+/-0.4 years). Estimation of bone tissue mineral density and blood levels of calcium, phosphorus and magnesium was performed during the pregnancy stage of 12 to 28 weeks.

Bone tissue mineral density study was conducted using ultrasonic densitometer Achiless Express, Lunar-General Electric Medical Systems.

Serum Ca, Mg and nonorganic P values study was performed on a Screen Master Plus (Switzerland) biochemical electrolyte analyzer, using standard array of reagents by Roche Diagnosis (Germany), using the facilities of Pavlodar maternity hospital.

Research results and their discussion

On the first stage of research, the examined pregnant subjects underwent ultrasonic densitometry, results of which are presented in Tables 1 and 2.

It is evident that average value of density index (DI) and t-criterion did not exhibit significant (over 1.0) decrease compared to the reference population data. Such is only registered in case of z-criterion. At the same time, Table 2 data indicate that the test group has women afflicted not only with osteopenia, but also osteoporosis.

Results indicate that the decrease of BTMD was revealed by z-criterion. We believe that this is due to availability within the test group of very young pregnant women who haven't achieved the peak of bone mass that is normally characteristic of more mature persons.

However, spotting of osteopenia and even osteoporosis by t-criterion, as the most adequate for BTMD analysis in this age group, also indicated a significant portion of deficiency cases, totaling at 17.5%.

Osteoporosis was revealed in 2 cases (1.7%) which, considering the total number of young pregnant women annually treated at the national facilities, presents a significant number and serious clinical problem.

Second stage of the study involved determination of the blood levels of calcium, magnesium and non-organic phosphorus, and comparative analysis of the collected data with the BTMD indicators. Table 3 presents the blood levels of the examined minerals

Concentration of general Ca in blood plasma drifted toward decrease among test groups with BTMD deficiency. Valid differences have been revealed during comparison of women group with normal BTMD and the one with osteoporosis (for 15.4%, p<0.05).

As for plasma [Mg.sup.2+], the test registered multidirectional tendencies in groups of pregnant subjects with osteopenia and osteoporosis. Value dispersion in the osteoporosis group (comprised of only 2 subjects, however) was higher than in the osteopenia group, and, obviously, much higher than in the group with no mineral density deficiency.

Conversely, blood levels of non-organic phosphorus had a tendency to decrease in the subgroup of osteopenia sufferers, and a tendency to increase in the subgroup of osteoporosis patients. Differences in this case were inconclusive.

Examined women underwent comparative analysis of consumption of milk products, as the primary source of calcium in the region concerned, as well as mineral-vitamin complexes administration, and juxtaposed that to the BTMD deficiency. Results are presented in Table 4.

Table 4 data indicate that normal BTMD was validly revealed primarily in women who regularly consumed milk or milk products throughout their lives. At the same time, conclusive difference from the normal BTMD group was exhibited by women who refrained from milk and milk products consumption and nutritional correction. Osteopenia among those was revealed in (36.8 [+ or -] 11.8)%, which is 18 times greater than in the normal BTMD group (p<0.05).

Due to the small number of pregnant women afflicted osteoporosis, conclusive differences for the BTMD indicators against other groups were not registered.

Results of correlational analysis of blood levels of calcium, magnesium and non-organic phosphorus against BTMD indicator are rendered in Table 5.

It is evident that there were significant and statistically valid correlations for total plasma levels of calcium against the BTMD parameters which were positive in all three cases.

As for plasma levels of Mg2+ and non-organic phosphorus, statistically valid positive correlations were revealed only in terms of DI (p<0.05).

Data acquired during research thus allow one to form the following conclusions:

1. Among young pregnant women during II trimester, rate of osteopenic syndrome amounts to 17.5%, including osteoporosis of 1.7%;

2. Development of osteopenic syndrome is attributed to general blood calcium deficiency;

3. Development of osteopenic syndrome in young pregnant women is associated with decreased dietary consumption of calcium (owing to exclusion of milk products);

4. Bone tissue mineral density is directly correlated with blood plasma levels of calcium.


Abdurazzakov, U., 2001. Osteoporosis (etiology, pathogenesis, clinical manifestations, diagnosis and treatment), Problems of osteoporosis in medicine, Conference Proceedings, Almaty.

Aspray, T., Francis, R., 2008. "Vitamin D deficiency--can old age learn from childhood?" Age Ageing., Vol.37(1), pp.6-7.

Benevolenskaya, L., 2003. Guide on osteoporosis, Moscow, BINOM, Knowledge lab.

Benevolenskaya, L., 2004. "Osteoporosis issue in contemporary medicine," Consilium medicum, Vol.6, No2, pp.96-100.

CRIG, 2004. Epidemiology, prevention, options for the clinical course and treatment of osteoporosis and its complications, Toolkit, Central Research Institute of Gastroenterology, Moscow.

Demin, V., 2005. Violations of the phosphorus-calcium metabolism in young children, Lectures on Pediatrics, RSMU.

Gafni, R., Baron, J., 2007. "Childhood bone mass acquisition and peak bone mass may not be important determinants of bone mass in late adulthood," Pediatrics, Vol.119 (Suppl. 2), pp.131-36.

Matkovic, V., Goel, P., Badenhop-Stevens N. et al., 2005. "Calcium supplementation and bone mineral density in females from childhood to young adulthood: a randomized controlled trial," Am J Clin Nutr., Vol.81(1), pp.175-88.

Melton, L., Thamer, M., Ray, N. et al., 1997. "Fractures attributable to osteoporosis: report from the national osteoporosis is foundation," J. Bone Miner. Res., Vol.12, pp.16-20.


Pavlodar Branch of Semei State Medical University, Kazakhstan

DI                      t-criterion           z-criterion

85.9 [+ or -] 4.7   -0.85 [+ or -] 0.04   -1.17 [+ or -] 0.04


Indicator     Normal BTMD   Osteopenia    Osteoporosis
              (d>-1.0)      (d<-1.0)      (d<-2.5)

              abs.    %     abs.    %     abs.    %

DI            107    89,2    12    10,0    1     0,8
t-criterion    99    82.5    19    15.8    2     1.7
z-criterion    88    73.3    28    23.3    4     3.3

TABLE 3. BLOOD LEVELS OF [CA.sup.2+], [MG.sup.2+] AND

Indicator                   Normal BTMD           Osteopenia
                          (d>-1.0), n = 99     (d<-1.0), n = 19

Plasma Ca, millimole/l   2.41 [+ or -] 0.13   2.20 [+ or -] 0.11

Plasma [Mg.sup.2+],      0.83 [+ or -] 0.05   0.81 [+ or -] 0.06

Non-organic phosphorus   1.12 [+ or -] 0.12   1.07 [+ or -] 0.03
content (millimole/l)

Indicator                    Osteoporosis
                           (d<-2.5), n = 2

Plasma Ca, millimole/l   2.04 [+ or -] 0.00 *

Plasma [Mg.sup.2+],      0.85 [+ or -] 0.10

Non-organic phosphorus   1.20 [+ or -] 0.10
content (millimole/l)

Notes: * difference from indicator
in control group are valid, p<0.05


Anamnesis data                               Normal BTMD
                                           (d>-1.0), n = 99

                                        abs.           %

Regular consumption of milk              93    93.9 [+ or -] 2.4
and milk products

Infrequent or nonexistent consumption    2     2.0 [+ or -] 1.4
of milk and milk products;
no nutritional correction.

Infrequent or nonexistent consumption    4     4.0 [+ or -] 2.0
of milk and milk products, with
nutritional correction

Anamnesis data                                Osteopenia
                                            (d<-1.0), n = 19

                                        abs.            %

Regular consumption of milk              10    52.6 [+ or -] 11.5 *
and milk products

Infrequent or nonexistent consumption    7     36.8 [+ or -] 11.1 *
of milk and milk products;
no nutritional correction.

Infrequent or nonexistent consumption    2      10.5 [+ or -] 7.0
of milk and milk products, with
nutritional correction

Anamnesis data                             Osteoporosis
                                          (d<-2.5), n = 2

                                        abs.           %

Regular consumption of milk              1     50.0 [+ or -] 35.4
and milk products

Infrequent or nonexistent consumption    1     50.0 [+ or -] 35.4
of milk and milk products;
no nutritional correction.

Infrequent or nonexistent consumption    0            0.0
of milk and milk products, with
nutritional correction


Indicator                    DI          t-criterion    z-criterion

                          r       p       r       p      r       P

Plasma Ca, mmole/l       0.49   <0.05   0.55    <0.05   0.38   <0.05

Plasma [Mg.sup.2+],      0.29   <0.05   -0.03   >0.05   0.17   >0.05

Non-organic phosphorus   0.37   <0.05   -0.15   >0.05   0.20   >0.05
content (mmole/l)
COPYRIGHT 2010 Prague Development Center
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Kabylova, Saule
Publication:Medical and Health Science Journal
Article Type:Report
Date:Apr 1, 2010
Previous Article:Course and treatment of hyperparathyroid crisis in children suffering from urolithiasis.
Next Article:Nanocapsular forms of preparations in preclinical studies.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters